<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font6" size="10" family="SymbolMT" color="#000000"/>
	<fontspec id="font7" size="10" family="GillSans" color="#ffffff"/>
	<fontspec id="font8" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font9" size="10" family="GillSans" color="#000000"/>
<text top="41" left="55" width="132" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">BMC Nuclear Medicine 2007, 7 :3<i>BMC Nuclear Medicine</i></text>
<text top="41" left="373" width="181" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.biomedcentral.com/1471-2385/7/3</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="44" segment_no="9" tag_type="text">Page 6 of 9<b>7</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="45" segment_no="10" tag_type="text">(page number not for citation purposes)</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="9" segment_no="4" tag_type="text">tocrit and RBC is probably attributable to a dilution effect</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="10" segment_no="4" tag_type="text">since patients were hydrated with 500 cc of IV normal</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="11" segment_no="4" tag_type="text">saline during the PET scan. Giving more credibility to the<i>(page number not for citation purposes)</i></text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="12" segment_no="4" tag_type="text">dilution hypothesis, haptoglobin measurements per-</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="13" segment_no="4" tag_type="text">formed on the last 3 patients having demonstrated such a</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="14" segment_no="4" tag_type="text">RBC decrease showed no evidence of hemolysis at the end</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="15" segment_no="4" tag_type="text">of the 18 F-FLT PET imaging session. Platelet and white</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="16" segment_no="4" tag_type="text">blood cell counts did not show any statistically significant</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="17" segment_no="4" tag_type="text">differences over time and no immediate effect of dilution.</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="18" segment_no="4" tag_type="text">This is likely because immediately available pools of such</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="19" segment_no="4" tag_type="text">cells exist in the body, helping to maintain their levels</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="20" segment_no="4" tag_type="text">despite hydration. Another important point is that the</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="21" segment_no="4" tag_type="text">patients whose medical records contain laboratory values</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="22" segment_no="4" tag_type="text">for times late after 18 F-FLT PET are those that had a more</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="23" segment_no="4" tag_type="text">prolonged post-operative course with more severe altera-</text>
<text top="686" left="55" width="171" height="9" font="font4" id="p1_t20" reading_order_no="24" segment_no="4" tag_type="text">tions expected in their laboratory values.</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="25" segment_no="8" tag_type="text">Statistical testing showed that the patients' albumin level</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="26" segment_no="8" tag_type="text">decreased slightly over time but its level remained within</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t23" reading_order_no="27" segment_no="5" tag_type="text">normal limits. However, Bonferroni post-test analysis</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t24" reading_order_no="28" segment_no="5" tag_type="text">shows that this change arises from the initial decrease</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t25" reading_order_no="29" segment_no="5" tag_type="text">(11.5%) between the pre- 18 F-FLT PET value and the</text>
<text top="544" left="313" width="241" height="10" font="font4" id="p1_t26" reading_order_no="30" segment_no="5" tag_type="text">immediate post- 18 F-FLT PET blood draw. This decrease is</text>
<text top="557" left="313" width="178" height="9" font="font4" id="p1_t27" reading_order_no="31" segment_no="5" tag_type="text">also likely explained by the hemodilution.</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t28" reading_order_no="32" segment_no="6" tag_type="text">No change was observed in the results of the neurological</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t29" reading_order_no="33" segment_no="6" tag_type="text">examinations performed before and immediately after the</text>
<text top="603" left="313" width="241" height="10" font="font4" id="p1_t30" reading_order_no="34" segment_no="6" tag_type="text">18 F-FLT PET study. Furthermore, a review of the clinical</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t31" reading_order_no="35" segment_no="6" tag_type="text">records for the 4 months following 18 F-FLT imaging</text>
<text top="627" left="313" width="176" height="9" font="font4" id="p1_t32" reading_order_no="36" segment_no="6" tag_type="text">revealed no new neurological complaints.</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t33" reading_order_no="37" segment_no="7" tag_type="text">The second approach used to estimate the toxicity of a</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t34" reading_order_no="38" segment_no="7" tag_type="text">radiotracer dose of 18 F-FLT is based on a comparison of</text>
<text top="674" left="313" width="241" height="11" font="font4" id="p1_t35" reading_order_no="39" segment_no="7" tag_type="text">the corresponding AUC 12 to the AUC 12 of the lowest and</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t36" reading_order_no="40" segment_no="7" tag_type="text">least toxic therapeutic regimen (50 ng*h/mL). For a 5 mCi</text>
<text top="697" left="313" width="241" height="10" font="font4" id="p1_t37" reading_order_no="41" segment_no="7" tag_type="text">radiotracer dose of 18 F-FLT and the lowest accepted spe-</text>
<text top="707" left="313" width="241" height="13" font="font4" id="p1_t38" reading_order_no="42" segment_no="7" tag_type="text">cific activity of 0.1 Ci/ μ mol, the imaging-derived AUC 12</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t39" reading_order_no="43" segment_no="7" tag_type="text">values ranged from 0.405 to 1.262 ng*h/mL with a mean</text>
<text top="414" left="55" width="65" height="9" font="font7" id="p1_t40" reading_order_no="3" segment_no="2" tag_type="title">Hepatic function</text>
<text top="414" left="55" width="37" height="9" font="font8" id="p1_t41" reading_order_no="2" segment_no="2" tag_type="title">Figure 1</text>
<text top="424" left="55" width="500" height="9" font="font8" id="p1_t42" reading_order_no="4" segment_no="3" tag_type="text">Hepatic function . Hepatic function: Alkaline phosphatase (A), total bilirubin (B), SGOT (C), SGPT (D), and albumin (E) levels</text>
<text top="435" left="55" width="499" height="9" font="font9" id="p1_t43" reading_order_no="5" segment_no="3" tag_type="text">sampled before FLT injection (Pre-FLT), up to 5 hours post-FLT (Immediate &lt;5 h), between 5 and 24 hours (5–24 h), between</text>
<text top="446" left="55" width="499" height="9" font="font9" id="p1_t44" reading_order_no="6" segment_no="3" tag_type="text">day 1 and 7 (1–7 d) and later than one week (&gt;1 wk) after FLT injection. Lines link all values for an individual patient over time.</text>
<text top="457" left="55" width="497" height="9" font="font9" id="p1_t45" reading_order_no="7" segment_no="3" tag_type="text">On Figure F (same data as Figure E) the mean +/- standard deviation for albumin is plotted over time. Dotted horizontal lines</text>
<text top="467" left="55" width="298" height="9" font="font9" id="p1_t46" reading_order_no="8" segment_no="3" tag_type="text">illustrate the upper and lower normal limits (reference range) for each test.</text>
</page>
</pdf2xml>
